MPLT: MapLight Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 6 sales totaling $1.06M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-15 | Kreitzer Anatol | Officer | $96K | |
| 2026-10-15 | Foff Erin Pennock | Officer | $124K | |
| 2026-10-15 | Hanson Kristopher | Officer | $73K | |
| 2026-10-15 | Lillie James Woodruff | Officer | $93K | |
| 2026-10-15 | Gillis Jonathan | CFO | $82K | |
| 2026-10-15 | Kroeger Christopher A. | CEO | $595K |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-20 | New 13G stake | Nan Fung Group Holdings Limited | 5.50% | SEC | |
| 2026-08-18 | 13D stake raised | Catalyst4, Inc. | 49.90% | +2.00 pts | SEC |
| 2026-08-03 | 13D amendment | Catalyst4, Inc. | 47.90% | SEC | |
| 2026-07-31 | Fell below 5% | Novo Holdings A/S | 4.90% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.